Trial Profile
Impact of etanercept co-therapy with Methotrexate and prednisone in Canadian patients with immune-mediated inflammatory diseases (IMIDs)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Jul 2018
Price :
$35
*
At a glance
- Drugs Etanercept (Primary) ; Methotrexate; Prednisone
- Indications Ankylosing spondylitis; Psoriasis; Psoriatic arthritis; Rheumatoid arthritis
- Focus Therapeutic Use
- 16 Jun 2018 Results (n=391) assessing co-treatment utilization and Etanercept treatment costs presented at the 19th Annual Congress of the European League Against Rheumatism
- 03 Jul 2017 New trial record
- 17 Jun 2017 Results presented at the 18th Annual Congress of the European League Against Rheumatism